Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements
 

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2010; 3:92-100, doi:10.1016/j.jcmg.2009.07.014
© 2010 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrió, I.
Right arrow Articles by Camici, P. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Carrió, I.
Right arrow Articles by Camici, P. G.

State-of-the-Art Paper

Cardiac Sympathetic Imaging With mIBG in Heart Failure

Ignasi Carrió, MD*,*, Martin R. Cowie, MD, MSc{dagger}, Junichi Yamazaki, MD§, James Udelson, MD||, Paolo G. Camici, MD*,{ddagger}

* Hospital Sant Pau, Barcelona, Spain
{dagger} National Heart & Lung Institute, Imperial College, London, United Kingdom
{ddagger} Clinical Sciences Centre, Imperial College, London, United Kingdom
§ Toho University School of Medicine, Tokyo, Japan
|| Tufts University School of Medicine, Boston, Massachusetts

* Reprint requests and correspondence: Dr. Ignasi Carrió, Hospital Sant Pau, Nuclear Medicine, Pare Claret 167, Barcelona 08025, Spain (Email: icarrio{at}santpau.cat).

Cardiac sympathetic imaging with meta-iodobenzylguanidine (mIBG) is a noninvasive tool to risk stratify patients with heart failure (HF). In patients with ischemic and nonischemic cardiomyopathy, cardiac mIBG activity is a very powerful predictor of survival. Cardiac sympathetic imaging can help in understanding how sympathetic overactivity exerts its deleterious actions, which may result in better therapy and outcome for patients with HF.

Key Words: mIBG • heart failure • cardiac sympathetic imaging • sudden death • prognosis

Abbreviations and Acronyms
  ACE = angiotensin-converting enzyme
  BNP = brain natriuretic peptide
  EP = electrophysiology
  HF = heart failure
  HMR = heart-to-mediastinum ratio
  LVEF = left ventricular ejection fraction
  mIBG = meta-iodobenzylguanidine
  MPI = myocardial perfusion imaging
  NE = norepinephrine
  NYHA = New York Heart Association
  SPECT = single-photon emission computed tomography
  WO = wash-out




This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
V. Dilsizian, Y. Chandrashekhar, and J. Narula
Introduction of New Tests: Low Are the Mountains, High the Expectations
J. Am. Coll. Cardiol. Img., January 1, 2010; 3(1): 117 - 119.
[Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link